SCHEMBL29176348

SCHEMBL29176348

O=C(Nc1ccccc1)c1cc2ccc(F)cc2[nH]1

nearest known ligand 0.71

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.71
▸ RAB9A P51151 4/20 0.71
▸ LMNA P02545 1/20 0.71
▸ SMN1; SMN2 Q16637 1/20 0.71
▸ TP53 P04637 1/20 0.59
▸ POLB P06746 1/20 0.59
▸ EGFR P00533 7/20 0.58
▸ PIK3CA P42336 7/20 0.58
▸ RXFP1 Q9HBX9 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ PTGDR2 Q9Y5Y4 1/20 0.53
▸ IDO1 P14902 1/20 0.53
▸ NSD2 O96028 1/20 0.52
▸ AR P10275 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2735818 0.89 NPC1 (0.71) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL7208136 0.83 NPC1 (1.00) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL29475123 0.83 NPC1 (1.00) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL29176363 0.83 NPC1 (0.71) NPC1RAB9ALMNASMN1; SMN2TP53
Hydrochloric Acid SCHEMBL16465542 0.82 NPC1 (0.97) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL29176334 0.80 NPC1 (0.52) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL17149688 0.80 NPC1 (0.52) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL19592646 0.80 NPC1 (0.66) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL17327557 0.79 EGFR (0.75) NPC1RAB9ALMNASMN1; SMN2TP53
SCHEMBL30147583 0.79 ALOX15 (0.68) NPC1RAB9ALMNARXFP1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117447381-A Indole amide derivative and its application in preparing beta 2 Use of adrenoreceptor allosteric antagonist medicaments 常州大学 2024-01-26 — — CN disclosed
Send feedback